Cargando…
Promise of metformin for preventing age-related cognitive dysfunction
The expanded lifespan of people, while a positive advance, has also amplified the prevalence of age-related disorders, which include mild cognitive impairment, dementia, and Alzheimer’s disease. Therefore, competent therapies that could improve the healthspan of people have great significance. Some...
Autores principales: | Madhu, Leelavathi N., Kodali, Maheedhar, Shetty, Ashok K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504370/ https://www.ncbi.nlm.nih.gov/pubmed/34380878 http://dx.doi.org/10.4103/1673-5374.320971 |
Ejemplares similares
-
Emerging Anti-Aging Strategies - Scientific Basis and Efficacy
por: Shetty, Ashok K., et al.
Publicado: (2018) -
Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus
por: Kodali, Maheedhar, et al.
Publicado: (2021) -
Novel Insights on Systemic and Brain Aging, Stroke, Amyotrophic Lateral Sclerosis, and Alzheimer’s Disease
por: Shetty, Ashok K., et al.
Publicado: (2019) -
Brain-Specific Increase in Leukotriene Signaling Accompanies Chronic Neuroinflammation and Cognitive Impairment in a Model of Gulf War Illness
por: Attaluri, Sahithi, et al.
Publicado: (2022) -
Resveratrol Prevents Age-Related Memory and Mood Dysfunction with Increased Hippocampal Neurogenesis and Microvasculature, and Reduced Glial Activation
por: Kodali, Maheedhar, et al.
Publicado: (2015)